SG11202007979UA - Dihydrochromene derivative - Google Patents
Dihydrochromene derivativeInfo
- Publication number
- SG11202007979UA SG11202007979UA SG11202007979UA SG11202007979UA SG11202007979UA SG 11202007979U A SG11202007979U A SG 11202007979UA SG 11202007979U A SG11202007979U A SG 11202007979UA SG 11202007979U A SG11202007979U A SG 11202007979UA SG 11202007979U A SG11202007979U A SG 11202007979UA
- Authority
- SG
- Singapore
- Prior art keywords
- dihydrochromene
- derivative
- dihydrochromene derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018052971 | 2018-03-20 | ||
| PCT/JP2019/011439 WO2019181939A1 (en) | 2018-03-20 | 2019-03-19 | Dihydrochromene derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202007979UA true SG11202007979UA (en) | 2020-09-29 |
Family
ID=67986459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202007979UA SG11202007979UA (en) | 2018-03-20 | 2019-03-19 | Dihydrochromene derivative |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US10807993B2 (en) |
| EP (1) | EP3770162B1 (en) |
| JP (2) | JP6733072B2 (en) |
| KR (1) | KR20200135401A (en) |
| CN (1) | CN111886237A (en) |
| AU (1) | AU2019239481B2 (en) |
| BR (1) | BR112020017481A8 (en) |
| CA (1) | CA3092255A1 (en) |
| CY (1) | CY1126034T1 (en) |
| DK (1) | DK3770162T3 (en) |
| EA (1) | EA202092206A1 (en) |
| ES (1) | ES2941771T3 (en) |
| FI (1) | FI3770162T3 (en) |
| HU (1) | HUE062256T2 (en) |
| MX (1) | MX2020009763A (en) |
| PH (1) | PH12020551497A1 (en) |
| PL (1) | PL3770162T3 (en) |
| PT (1) | PT3770162T (en) |
| SG (1) | SG11202007979UA (en) |
| TW (1) | TW201941774A (en) |
| WO (1) | WO2019181939A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3770162T (en) * | 2018-03-20 | 2023-03-23 | Sumitomo Pharma Co Ltd | Dihydrochromene derivative |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001045707A1 (en) * | 1999-12-21 | 2001-06-28 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| US20090111805A1 (en) * | 2005-02-24 | 2009-04-30 | Pfizer Inc. | Bicyclic heteroaromatic derivatives useful as anticancer agents |
| AR058065A1 (en) * | 2005-09-27 | 2008-01-23 | Novartis Ag | CARBOXYAMINE COMPOUNDS AND USE OF THE SAME PHARMACEUTICAL COMPOSITIONS. |
| EP1847542A1 (en) * | 2006-04-21 | 2007-10-24 | Laboratorios del Dr. Esteve S.A. | Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor |
| EP2200431B1 (en) | 2007-09-10 | 2016-07-20 | Boston Biomedical, Inc. | Novel compositions and methods for cancer treatment |
| SG11201710694YA (en) * | 2015-06-22 | 2018-01-30 | Sumitomo Dainippon Pharma Co Ltd | Bicyclic heterocyclic amide derivative |
| KR20180028456A (en) * | 2015-06-22 | 2018-03-16 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 1,4-disubstituted imidazole derivatives |
| WO2017146128A1 (en) * | 2016-02-26 | 2017-08-31 | 大日本住友製薬株式会社 | Imidazolylamide derivative |
| TW201821105A (en) * | 2016-10-20 | 2018-06-16 | 美商弗瑪治療公司 | Methods using HDAC11 inhibitors |
| PT3770162T (en) * | 2018-03-20 | 2023-03-23 | Sumitomo Pharma Co Ltd | Dihydrochromene derivative |
| JP2020019752A (en) * | 2018-08-03 | 2020-02-06 | 大日本住友製薬株式会社 | Chroman derivative |
-
2019
- 2019-03-19 PT PT197707557T patent/PT3770162T/en unknown
- 2019-03-19 CN CN201980020335.0A patent/CN111886237A/en active Pending
- 2019-03-19 JP JP2020507833A patent/JP6733072B2/en active Active
- 2019-03-19 EP EP19770755.7A patent/EP3770162B1/en active Active
- 2019-03-19 TW TW108109362A patent/TW201941774A/en unknown
- 2019-03-19 ES ES19770755T patent/ES2941771T3/en active Active
- 2019-03-19 HU HUE19770755A patent/HUE062256T2/en unknown
- 2019-03-19 AU AU2019239481A patent/AU2019239481B2/en active Active
- 2019-03-19 WO PCT/JP2019/011439 patent/WO2019181939A1/en unknown
- 2019-03-19 DK DK19770755.7T patent/DK3770162T3/en active
- 2019-03-19 KR KR1020207029401A patent/KR20200135401A/en not_active Application Discontinuation
- 2019-03-19 EA EA202092206A patent/EA202092206A1/en unknown
- 2019-03-19 CA CA3092255A patent/CA3092255A1/en active Pending
- 2019-03-19 SG SG11202007979UA patent/SG11202007979UA/en unknown
- 2019-03-19 MX MX2020009763A patent/MX2020009763A/en unknown
- 2019-03-19 PL PL19770755.7T patent/PL3770162T3/en unknown
- 2019-03-19 FI FIEP19770755.7T patent/FI3770162T3/en active
- 2019-03-19 BR BR112020017481A patent/BR112020017481A8/en unknown
-
2020
- 2020-03-03 US US16/808,246 patent/US10807993B2/en active Active
- 2020-07-08 JP JP2020117566A patent/JP7247144B2/en active Active
- 2020-07-31 US US16/944,482 patent/US11639357B2/en active Active
- 2020-09-18 PH PH12020551497A patent/PH12020551497A1/en unknown
-
2023
- 2023-03-21 US US18/187,124 patent/US20230219970A1/en active Pending
- 2023-05-26 CY CY20231100250T patent/CY1126034T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT3770162T (en) | 2023-03-23 |
| JP2020180140A (en) | 2020-11-05 |
| PL3770162T3 (en) | 2023-06-05 |
| JPWO2019181939A1 (en) | 2020-06-18 |
| EA202092206A1 (en) | 2020-12-15 |
| KR20200135401A (en) | 2020-12-02 |
| WO2019181939A1 (en) | 2019-09-26 |
| US20210002290A1 (en) | 2021-01-07 |
| AU2019239481A1 (en) | 2020-09-10 |
| EP3770162B1 (en) | 2023-03-15 |
| US20230219970A1 (en) | 2023-07-13 |
| CN111886237A (en) | 2020-11-03 |
| US10807993B2 (en) | 2020-10-20 |
| TW201941774A (en) | 2019-11-01 |
| FI3770162T3 (en) | 2023-06-02 |
| PH12020551497A1 (en) | 2021-09-01 |
| EP3770162A4 (en) | 2021-12-01 |
| US11639357B2 (en) | 2023-05-02 |
| DK3770162T3 (en) | 2023-04-24 |
| BR112020017481A8 (en) | 2022-12-06 |
| MX2020009763A (en) | 2020-10-08 |
| BR112020017481A2 (en) | 2020-12-22 |
| CA3092255A1 (en) | 2019-09-26 |
| EP3770162A1 (en) | 2021-01-27 |
| JP2023075288A (en) | 2023-05-30 |
| ES2941771T3 (en) | 2023-05-25 |
| US20200216461A1 (en) | 2020-07-09 |
| AU2019239481B2 (en) | 2022-11-24 |
| JP7247144B2 (en) | 2023-03-28 |
| CY1126034T1 (en) | 2023-11-15 |
| HUE062256T2 (en) | 2023-10-28 |
| JP6733072B2 (en) | 2020-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3793565T3 (en) | Mcl-1-inhibitorer | |
| DK3467457T3 (en) | Vibrationssensor | |
| DK3759096T3 (en) | Cd73-inhibitorer | |
| HUE060181T2 (en) | Substituted alkoxypyridinyl indolsulfonamides | |
| CA185383S (en) | Casque | |
| CA185382S (en) | Casque | |
| CA185384S (en) | Casque | |
| CA185385S (en) | Casque | |
| DK3773537T3 (en) | Stat3-hæmmere | |
| DK3554057T3 (en) | Audioheadsetsystem | |
| DK3768830T3 (en) | Cancerterapi | |
| IL283990A (en) | Substituted oxopyridine derivatives | |
| DK3613739T3 (en) | Integrin-antagonister | |
| DK3753395T3 (en) | Indvendigt luftstyringssystem | |
| CA184990S (en) | Uroflowmeter | |
| DK3633783T3 (en) | Universal-powerbank | |
| IL290964A (en) | 2-aminoquinazolinone derivative | |
| IL279938A (en) | Spirochromane derivatives | |
| CA184994S (en) | Uroflowmeter | |
| SI3796975T1 (en) | Sulfonylaminobenzamide derivatives | |
| DK3768906T3 (en) | Træmodul | |
| DK3674425T3 (en) | Stålwire | |
| DK3650069T3 (en) | Trakeostomiventil | |
| SG11202007979UA (en) | Dihydrochromene derivative | |
| SG11202006837XA (en) | Dihydroindolizinone derivative |